ROUTINE TRAVEL VACCINE. SCOTTSDALE, AZ

Polio Vaccine in Arizona

Whether you need to start a childhood series, catch up on missed doses, or add a single travel booster before heading to Afghanistan, Pakistan, or parts of sub-Saharan Africa, TravelBug Health has you covered. Expert guidance and same-day appointments often available.

Call (480) 435-2774 Book Online

~99% effective . 3 to 4 dose series . Long-term protection

QUICK FACTS

Polio is a highly infectious disease caused by the poliovirus, which can lead to permanent paralysis and even death.

  • The incidence of polio is on the increase, especially in Africa and in areas of conflict.
  • Polio vaccination is the safest and most effective way to prevent polio.
  • A polio vaccine booster may be recommended for travel to some countries in Africa, South Asia and the Middle East where wild polio virus still exists.

Polio: Paralysis With No Cure, Prevented by a Simple Shot

Poliomyelitis (polio) is a highly contagious viral disease caused by poliovirus. It spreads primarily through fecal-oral contact and contaminated water. Most infections are mild or produce no symptoms at all. But in approximately 1 in 200 infections, the virus invades the nervous system and causes irreversible paralysis. Of those who become paralyzed, 5 to 10 percent die when the virus immobilizes the muscles that control breathing.

There is no cure. Once paralysis occurs, no treatment reverses it. The only defense is vaccination. The inactivated poliovirus vaccine (IPV) used in the United States today cannot cause polio, is highly effective, and is recommended for every child and adult who lacks documented immunity.

Wild poliovirus type 2 was certified eradicated globally in 2015, and type 3 in 2019. Wild poliovirus type 1 still circulates in Afghanistan and Pakistan. Circulating vaccine-derived poliovirus (cVDPV) remains a concern in parts of sub-Saharan Africa. The U.S. had its last case of wild poliovirus in 1979. That milestone holds only because vaccination rates remain high.

Who Should Receive the Polio Vaccine

The CDC and the Advisory Committee on Immunization Practices (ACIP) recommend the polio vaccine for:

  • All infants and children in the United States, as part of the routine immunization schedule
  • Adults who were never vaccinated or who did not complete the full primary series
  • Travelers to countries where wild poliovirus or circulating vaccine-derived poliovirus remains active, including Afghanistan, Pakistan, and affected areas of Africa
  • Adults who completed childhood vaccination and are traveling to a poliovirus-endemic or epidemic area. A single lifetime booster dose is recommended
  • Healthcare workers, laboratory personnel, and fieldworkers who may handle poliovirus specimens or work in endemic settings

Medically Reviewed By

Norman J. Bizon, PA-C, CTH
Medical Director, 30+ years clinical experience

Tessa E. McFall, ASN, EMT
Travel Health Clinician

Last updated April 21, 2026

DESTINATIONS

Where Polio Remains a Risk

Wild poliovirus type 1 still circulates in Afghanistan and Pakistan. Circulating vaccine-derived poliovirus has affected multiple countries in sub-Saharan Africa. The CDC and WHO update recommendations regularly. Always confirm at your consultation.

Afghanistan. Wild poliovirus type 1 continues to circulate. All travelers should be up to date on polio vaccination before arrival. Adults who completed a childhood series should receive one lifetime booster dose. Travelers spending four or more weeks in Afghanistan should carry documentation showing IPV was received within the prior twelve months, as exit health checkpoints may request proof.

Pakistan. Wild poliovirus type 1 also persists in Pakistan, particularly in the northwest and border regions with Afghanistan. The same recommendations apply: ensure vaccination is current, receive a booster if previously vaccinated, and carry documentation for stays of four or more weeks.

Sub-Saharan Africa (countries with active cVDPV). Circulating vaccine-derived poliovirus outbreaks have affected multiple African nations in recent years, including countries in Central, East, and West Africa. The specific countries with active transmission change over time. We pull current CDC and WHO outbreak maps at your appointment and advise based on your exact destination and planned activities.

Saudi Arabia (Hajj and Umrah). Saudi health authorities have periodically required proof of oral or inactivated polio vaccination for pilgrims arriving from countries with active poliovirus transmission. Requirements vary by year and country of origin. Confirm current requirements at your consultation.

Countries with documented cVDPV transmission. Beyond Afghanistan and Pakistan, the WHO recommends that travelers to any country with confirmed circulating vaccine-derived poliovirus outbreaks ensure they are fully vaccinated. This includes parts of Central Africa, West Africa, and the Horn of Africa depending on current outbreak status.

Long-stay travelers anywhere in the region. The WHO advises that travelers who spend four or more weeks in a polio-affected country should carry documentation of IPV vaccination received within the prior twelve months. Some countries perform exit screening and request proof of vaccination before allowing departure.

Healthcare workers and field staff. NGOs, relief organizations, and government agencies deploying staff to endemic areas routinely require documented polio vaccination. A booster within the past ten years is typically expected for occupational deployments to high-risk settings.

Outbreak status changes. We pull current CDC and WHO guidance for your specific itinerary at your appointment.

Required for U.S. children (routine schedule): 4 doses of IPV at 2 months, 4 months, 6 to 18 months, and 4 to 6 years.

Catch-up for unvaccinated adults: 3-dose primary series over 6 to 12 months.

Booster for vaccinated adult travelers to endemic areas: One lifetime dose before travel to Afghanistan, Pakistan, or countries with active cVDPV.

Recommendations change. We review your specific itinerary and vaccination history at your appointment.

TRAVEL DOCUMENTATION

Vaccination Records for Polio Travel Requirements

Unlike yellow fever, polio vaccination does not require a WHO-issued international certificate for most travelers. But documentation matters more than many people expect, particularly for travel to or through endemic regions.

What you receive at your TravelBug Health appointment

  • Updated immunization record noting the vaccine administered, lot number, date, and administering clinician
  • Clinician-signed documentation suitable for submission to employers, schools, or travel programs that require proof of polio vaccination
  • Itemized receipt with CPT codes and NPI for insurance submission or employer reimbursement
  • Ongoing record access. If you need a replacement record later, we can reissue from our files

When proof of vaccination may be required

  • Exit requirements from endemic countries. The WHO advises travelers spending four or more weeks in Afghanistan, Pakistan, or countries with active cVDPV to carry proof of IPV vaccination received within the prior twelve months. Some countries check documentation at departure.
  • Saudi Arabia (Hajj and Umrah). Saudi health authorities have periodically required proof of polio vaccination for pilgrims arriving from countries with active poliovirus transmission. Requirements change seasonally. Confirm at your consultation.
  • Employer and program requirements. Relief organizations, NGOs, and some government agencies deploying staff to endemic areas routinely require documented polio vaccination.

Carry your vaccination documentation alongside your passport when traveling to endemic or high-risk regions.

SAFETY

Who Should Not Get the Polio Vaccine, or Should Consult First

IPV is an inactivated (killed) vaccine. It cannot cause polio. It is one of the safest vaccines in routine use.

Contraindications and Precautions

Vaccination should be deferred or discussed in detail if you:

  • Have had a severe allergic reaction (anaphylaxis) to a prior dose of IPV
  • Are allergic to neomycin, streptomycin, or polymyxin B. These antibiotics are used in trace amounts during vaccine production
  • Are experiencing a moderate to severe acute illness. Defer until recovery. Mild illness with no fever is not a reason to delay
  • Are pregnant. IPV is an inactivated vaccine and no evidence of fetal harm exists, but vaccination is generally deferred unless travel to an endemic area is unavoidable and the risk of exposure is genuine

Safe for Immunocompromised Patients

Because IPV contains no live virus, it is safe for people who are immunocompromised, including those with HIV, cancer, organ transplants, or on immunosuppressive medications. Vaccination is especially important for immunocompromised individuals who may be at higher risk of severe illness if exposed to poliovirus.

Immunocompromised patients may have a reduced immune response to the vaccine. We discuss timing and dose considerations at your consultation.

Call to Discuss Your Case

SPECIAL CONSIDERATIONS

Specific Situations We Handle

Travelers to Afghanistan or Pakistan

Wild poliovirus type 1 remains endemic in both countries. Adults who completed childhood vaccination should receive a one-time booster before travel. Travelers spending four or more weeks should carry documentation of IPV given within the preceding twelve months, as exit health checks occur at some border crossings and airports.

Travel to Sub-Saharan Africa

Circulating vaccine-derived poliovirus outbreaks have affected multiple African countries in recent years. The specific countries with active transmission change over time. We pull current CDC and WHO outbreak maps at your appointment and advise based on your exact destination and planned activities.

No Vaccination Records

Many adults vaccinated in the 1970s or 1980s received OPV (oral polio vaccine) and have no paper records. CDC guidance is simply to complete or repeat the series. There is no harm in additional IPV doses if prior vaccination status is uncertain.

Pregnancy

IPV is an inactivated vaccine and no studies have shown fetal harm. Vaccination is generally deferred during pregnancy unless travel to a polio-endemic region is unavoidable. If you are pregnant and must travel to Afghanistan, Pakistan, or an area with active cVDPV, we walk through a detailed risk-benefit discussion and can vaccinate when the clinical case is clear.

Children Vaccinated Abroad with OPV

Children who received OPV (oral polio vaccine) outside the United States may still benefit from completing an IPV series to ensure documented immunity recognized in the U.S. We review records from foreign vaccination programs and advise on the minimum number of additional IPV doses needed.

Immunocompromised Patients

IPV is safe for immunocompromised individuals and is preferred over OPV in this population. Patients on biologics, chemotherapy, or post-transplant immunosuppression should receive IPV. Immune response may be reduced, so timing around therapy cycles and coordination with the treating physician can optimize protection.

EFFECTIVENESS

A Complete Series Is Nearly 100% Protective.

Studies have consistently shown that two doses of IPV provide approximately 90 percent protection against paralytic polio. After three or more doses, protection rises to approximately 99 percent and is long-lasting for the vast majority of recipients.

The inactivated formulation used in the United States since 2000 produces strong serum antibody responses that prevent viral spread to the nervous system. Protection from a completed childhood series persists into adulthood, though adults traveling to endemic areas are advised to receive one lifetime booster to ensure robust immunity.

IPV does not contain live virus and cannot cause vaccine-associated paralytic polio (VAPP), a rare risk that existed with the older oral poliovirus vaccine. Every dose given in the U.S. today is IPV.

~99%

Effectiveness
After complete series

1

Booster
For vaccinated adult travelers

3 to 4 doses

Primary series for full and lasting protection in children and unvaccinated adults

COST AND INSURANCE

What to Expect at Checkout

Routine childhood polio vaccination is typically covered by insurance and the Vaccines for Children (VFC) program. Travel boosters and adult catch-up doses follow different coverage rules.

At Your Appointment

You’ll be charged for:

  • Travel health consultation (itinerary-based risk assessment)
  • The IPV vaccine dose or doses
  • Vaccination documentation suitable for travel or employer requirements
  • Any other vaccines or prescriptions you elect

Pricing varies based on services. Call (480) 435-2774 for current pricing.

What to Ask Your Insurer

Before your appointment, call the member services number on your insurance card and ask:

  • Does my plan cover IPV for adults or as a travel vaccine?
  • What CPT code do I submit? IPV is typically 90713
  • Do I need pre-authorization?
  • Can I apply HSA or FSA funds?

For Reimbursement

After your appointment, we provide a detailed itemized receipt with:

  • CPT codes
  • Diagnosis codes
  • Clinician’s NPI
  • Itemized line items

Children covered by Medicaid or the VFC program may receive IPV at no cost. Ask about eligibility when you call.

SAFETY PROFILE

Side Effects and Safety

IPV is one of the best-tolerated vaccines in routine use. Because it contains no live virus, it cannot cause polio.

COMMON. 14 to 29%

Mild Local Reactions

  • Soreness, redness, or swelling at the injection site (resolves within 1 to 2 days)
  • Mild tenderness with pressure on the arm
  • Fussiness or mild irritability in infants, typically resolving within 24 hours

UNCOMMON

Systemic Reactions

Low-grade fever has been reported after IPV, most commonly when it is co-administered with other vaccines in infancy. Mild fatigue or fussiness beyond the first 24 hours is uncommon. Systemic reactions to IPV alone are much less frequent than with many other childhood vaccines.

VERY RARE

Severe Allergic Reaction

Anaphylaxis is extremely rare with IPV. It can occur with virtually any injectable medication. We observe patients briefly after vaccination. If you have a known allergy to neomycin, streptomycin, or polymyxin B, tell us before your appointment so we can take appropriate precautions.

No vaccine-associated paralytic polio with IPV: The older oral poliovirus vaccine (OPV) carried a very small risk of vaccine-associated paralytic polio, approximately 1 case per 2.4 million doses. The United States switched exclusively to IPV in 2000, eliminating this risk entirely. IPV cannot revert to a virulent form and cannot cause polio in the recipient or their contacts.

WHAT HAPPENS NEXT

After Your Polio Vaccination

1

Expect Very Little

Most people notice only mild soreness at the injection site, if anything at all. Low-grade fever is uncommon. Resume normal activity immediately. Acetaminophen or ibuprofen can address soreness if needed.

2

Keep Your Records

Store your updated immunization record with your passport and travel documents. For travel to endemic areas, carry documentation of your vaccination date. Some countries request proof of IPV for travelers staying four or more weeks.

3

Return for Remaining Doses

If you are starting or completing a series, schedule your follow-up doses before your departure date. We map the timing at your first visit. Minimum intervals between doses must be respected to ensure full protection.

4

Coordinate Other Travel Vaccines

IPV can be given the same day as most other vaccines. If your itinerary includes Afghanistan, Pakistan, or sub-Saharan Africa, you may also need hepatitis A, typhoid, or other vaccines. We review the full picture at your consultation.

WHY A TRAVEL CLINIC

TravelBug vs. Primary Care or Pharmacy

IPV is available at many locations, but travel medicine involves more than administering a single shot. Here is what we offer that general providers typically cannot match.

TravelBug Health

  • Specialist-led itinerary-based risk consultation
  • Complete IPV series and travel booster available
  • Clinician-signed documentation for endemic-area exit requirements
  • Same-day or next-day appointments often available
  • Coordinates full panel of travel vaccines
  • Catch-up series for unvaccinated adults and children

PCP or Retail Pharmacy

  • Limited or general consultation only
  • May not stock all IPV formulations or schedules
  • Documentation for exit requirements varies widely
  • Variable scheduling
  • Limited stock of travel-specific vaccines
  • Adult catch-up series often inconsistent

SCHEDULE YOUR VACCINATION

TravelBug Health in Scottsdale

We are a travel medicine clinic in the heart of the Phoenix metro. We see children, adults, and travelers of all kinds: people starting routine series, adults who never completed childhood vaccination, and seasoned travelers heading to endemic regions who need a booster and documentation before departure.

TravelBug Health Travel Clinic
8603 E Royal Palm Rd, Suite 120
Scottsdale, AZ 85258

Phone: (480) 435-2774
Email: team@travelbughealth.com
Hours: Monday to Friday, 9:00 AM to 5:00 PM (by appointment)

Call Now Book Online

Just minutes from across the Valley

North Scottsdale near the 101 and Shea Blvd:

No referral required. Same-day and next-day appointments are often available. Call us with your itinerary and vaccination history and we will find a time that works.

QUESTIONS TRAVELERS ASK

Frequently Asked Questions

Yes. The CDC and ACIP recommend four doses of IPV for all U.S. children as part of the routine immunization schedule: at 2 months, 4 months, 6 to 18 months, and again at 4 to 6 years. This series produces approximately 99 percent protection against paralytic polio. It is one of the most important vaccines in the childhood schedule and is required for school enrollment in Arizona.

If you were born in the U.S. and attended school, you almost certainly received the polio vaccine. Most adults vaccinated before 2000 received the oral poliovirus vaccine (OPV). Adults vaccinated after 2000 received IPV. Both provide effective protection, though documentation of OPV doses may vary. If you have records showing three or more doses, you are considered fully vaccinated for routine purposes. If records are unavailable, it is safe to repeat the series.

For most U.S. adults who completed a childhood series, no routine booster is needed unless you are traveling to a polio-endemic area. The CDC recommends that adults in this situation receive one lifetime booster dose of IPV before travel to Afghanistan, Pakistan, or countries with active circulating vaccine-derived poliovirus outbreaks. This is a one-time recommendation, not a recurring one.

Yes, strongly. Wild poliovirus type 1 continues to circulate in both countries. The CDC recommends that all travelers be up to date on polio vaccination before visiting. Adults who completed a childhood series should receive one lifetime booster dose. If you will spend four or more weeks in either country, you should also carry documentation showing IPV was administered within the twelve months prior to departure, as some exit health checkpoints may request it.

There is no universal entry requirement for polio vaccination when visiting African countries. However, circulating vaccine-derived poliovirus outbreaks have occurred across multiple sub-Saharan African nations. The WHO advises travelers to countries with active cVDPV transmission to ensure they are fully vaccinated and to carry proof of vaccination if staying four or more weeks. Saudi Arabia has also required proof of polio vaccination for Hajj and Umrah pilgrims arriving from certain affected countries. We review current outbreak maps at your consultation and advise based on your specific destination.

IPV (inactivated poliovirus vaccine) is an injected vaccine containing killed poliovirus. It cannot cause polio under any circumstances. OPV (oral poliovirus vaccine) is a live-attenuated vaccine administered by mouth. OPV was highly effective and was instrumental in global eradication efforts, but it carried a very small risk of vaccine-associated paralytic polio (approximately 1 case per 2.4 million doses). The United States switched exclusively to IPV in 2000. OPV is still used in some international eradication campaigns but is not available in U.S. clinics.

Adults who were never vaccinated against polio need a three-dose primary series: the first dose at the initial visit, a second dose one to two months later, and a third dose six to twelve months after the second. If you need protection before an upcoming trip and cannot complete the full series, even one or two doses provide meaningful partial protection. We discuss the fastest schedule that fits your timeline at your consultation.

Yes. IPV is an inactivated vaccine containing no live virus, making it safe for immunocompromised patients including those with HIV, cancer, organ transplants, or who are taking immunosuppressive medications. Vaccination is particularly important for these individuals because poliovirus infection can be more severe in people with weakened immune systems. The immune response to the vaccine may be reduced in immunocompromised patients, so timing and dosing are factors we review at your consultation.

IPV is an inactivated vaccine and no evidence of fetal harm exists in available data. ACIP guidance indicates that IPV may be given to pregnant travelers when travel to an endemic area is unavoidable. In practice, vaccination during pregnancy is generally deferred unless the travel risk is genuine and the trip cannot be postponed. If you are pregnant and traveling to Afghanistan, Pakistan, or an area with active cVDPV, call us to discuss your specific situation.

Protection from a completed childhood series is long-lasting and generally considered sufficient for life for people who remain in non-endemic settings. Adults traveling to endemic areas are advised to receive one booster. There is currently no evidence supporting the need for repeat boosters beyond that single travel dose for otherwise healthy adults. We review your history and advise accordingly at your appointment.

IPV is one of the mildest vaccines in routine use. The most common reaction is mild soreness or redness at the injection site, reported in roughly 14 to 29 percent of recipients. Low-grade fever is uncommon and most often occurs when IPV is given alongside other childhood vaccines. Severe allergic reactions are extremely rare. IPV cannot cause polio.

It depends on the number of doses documented. Children who received three or more OPV doses are generally considered adequately vaccinated for international purposes. However, U.S. schools and programs typically require IPV-documented records. If your child’s vaccination history is incomplete or uses OPV, we review the records and determine the minimum number of additional IPV doses needed to meet U.S. standards and ensure full protection.

For most travelers to Western Europe, the Caribbean, Mexico, or popular Asian tourist destinations, the practical risk of polio exposure is very low. The risk becomes meaningful for travel to Afghanistan, Pakistan, and countries with active cVDPV outbreaks in Africa. Unvaccinated or incompletely vaccinated travelers to these regions face real exposure risk. Even for lower-risk destinations, being up to date on polio vaccination is a baseline expectation for all international travel.

Routine childhood IPV is covered by most insurance plans and the Vaccines for Children (VFC) program. Travel booster doses for adults are often considered elective and may not be covered. HSA and FSA funds can generally be applied. We provide itemized receipts with CPT code 90713 and the appropriate office-visit code so you have everything needed to file a claim or apply for reimbursement.

If you only need a single booster dose, protection is considered optimal within a few weeks. If you need to start a primary series, plan at least six to twelve months before travel to complete the full three-dose schedule. If time is short, even partial series completion provides meaningful protection. Call us as early as possible so we can build the best schedule around your departure date.

Yes. TravelBug Health is located in North Scottsdale and serves the entire Phoenix metro area. We offer IPV for routine catch-up, travel boosters, and pediatric scheduling. Call (480) 435-2774 to schedule, or book online. Same-day and next-day appointments are often available.

Stay Protected. Travel Ready.

Schedule Your Polio Vaccination

No referral required. Whether you need a routine series, an adult catch-up, or a one-time travel booster before heading to an endemic region, we handle the consultation, the vaccine, and the documentation. All in one visit.

Call (480) 435-2774 Book Online